SSY Group (2005) Price & Analysis

Compare

6 Followers

2005 Stock Chart & Stats

HK$2.93

HK$0.03(0.93%)

At close: Jan 09 4:00 PM EST

HK$2.93

HK$0.03(0.93%)

Day’s Range― - ―

52-Week RangeHK$2.58 - HK$3.50

Previous CloseN/A

Volume3.59M

Average Volume (3M)5.65M

Market Cap

HK$8.91B

Enterprise ValueHK$11.09B

Total Cash (Recent Filing)HK$1.52B

Total Debt (Recent Filing)HK$4.02B

Price to Earnings (P/E)13.5

Beta0.60

Next Earnings

Aug 31, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.93%

Share Statistics

EPS (TTM)0.10

Shares Outstanding2,951,113,300

10 Day Avg. Volume4,536,404

30 Day Avg. Volume5,652,093

Financial Highlights & Ratios

PEG Ratio-0.55

Price to Book (P/B)1.46

Price to Sales (P/S)1.83

P/FCF Ratio-214.12

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)1.48

Revenue Forecast (FY)HK$32.04B

Bulls Say, Bears Say

Bulls Say

Strong ProfitabilityA consistent high gross profit margin indicates effective cost management and pricing power, contributing to sustainable profitability.

Stable Balance SheetA moderate leverage ratio reflects prudent financial management, ensuring long-term stability and flexibility in capital allocation.

Effective Use Of EquityHigh return on equity indicates efficient use of shareholders' funds to generate earnings, enhancing investor confidence and company value.

Bears Say

Revenue DeclineA decline in revenue growth may signal challenges in market expansion or competitive pressures, potentially impacting future earnings.

Cash Flow ChallengesInconsistent cash flow can hinder the company's ability to fund operations and growth initiatives, posing risks to financial health.

Earnings DeclineA significant decline in earnings per share growth indicates potential operational or market challenges, affecting investor sentiment and valuation.

SSY Group News

SSY Group Issues Profit Warning as Pricing and Demand Pressures Hit 2025 Earnings

An update from SSY Group ( ($HK:2005) ) is now available. SSY Group has warned that profit attributable...

6d ago

SSY Group Wins China Approval for Propranolol Bulk Drug

The latest announcement is out from SSY Group ( ($HK:2005) ). SSY Group Limited has obtained approval from...

9d ago

SSY Group Wins 45 Drug Selections in China’s National Centralised Procurement Renewal

SSY Group ( ($HK:2005) ) has issued an update. SSY Group Limited has secured selection for 45 of...

12d ago

SSY Group Wins NMPA Approvals for Two New Bulk Drug Products

SSY Group ( ($HK:2005) ) has issued an update. SSY Group Limited has secured approvals from China’s National...

13d ago

SSY Group Wins NMPA Approval for New Cardiac Injection

The latest update is out from SSY Group ( ($HK:2005) ). SSY Group Limited has secured approval from...

23d ago

SSY Group Wins China Approval for New Specification of Nutritional Injection

SSY Group ( ($HK:2005) ) has issued an update. SSY Group Limited has received approval from China’s National...

27d ago

SSY Group Wins China Approval for New Hypertension Combination Drug

SSY Group ( ($HK:2005) ) has provided an announcement. SSY Group Limited has secured approval from China’s National...

2M ago

SSY Group Wins NMPA Approval for Sodium Glycerophosphate Injection

SSY Group ( ($HK:2005) ) has provided an announcement. SSY Group Limited has received approval from China’s National...

2M ago

SSY Group Renews Key Connected Transactions with Sichuan Kelun for 2026

SSY Group ( ($HK:2005) ) has shared an update. SSY Group has renewed its core commercial arrangements with...

2M ago

SSY Group Gains Approval for New Drug Developments

The latest update is out from SSY Group ( ($HK:2005) ). SSY Group Limited has received approval from...

2M ago

2005 FAQ

What was SSY Group Limited’s price range in the past 12 months?

SSY Group Limited lowest stock price was HK$2.58 and its highest was HK$3.50 in the past 12 months.

What is SSY Group Limited’s market cap?

SSY Group Limited’s market cap is HK$8.91B.

When is SSY Group Limited’s upcoming earnings report date?

SSY Group Limited’s upcoming earnings report date is Aug 31, 2026 which is in 190 days.

How were SSY Group Limited’s earnings last quarter?

SSY Group Limited released its earnings results on Aug 28, 2025. The company reported HK$0.096 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.096.

Is SSY Group Limited overvalued?

According to Wall Street analysts SSY Group Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does SSY Group Limited pay dividends?

SSY Group Limited pays a Quarterly dividend of HK$0.05 which represents an annual dividend yield of 4.93%. See more information on SSY Group Limited dividends here

What is SSY Group Limited’s EPS estimate?

SSY Group Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does SSY Group Limited have?

SSY Group Limited has 2,951,113,300 shares outstanding.

What happened to SSY Group Limited’s price movement after its last earnings report?

SSY Group Limited reported an EPS of HK$0.096 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.052%.

Which hedge fund is a major shareholder of SSY Group Limited?

Currently, no hedge funds are holding shares in HK:2005

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

SSY Group Stock Smart Score

Neutral

News Sentiment

Very Bearish

Bullish news 0%
Bearish news 100%

Technicals

Fundamentals

Return on Equity

9.12%

Trailing 12-Months

Asset Growth

1.39%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

SSY Group Limited

SSY Group (2005) is a diversified company specializing in the manufacturing and distribution of pharmaceuticals and healthcare products. With a strong emphasis on quality and innovation, SSY Group operates in various sectors including generic pharmaceuticals, active pharmaceutical ingredients (APIs), and medical devices. The company aims to improve healthcare outcomes through its extensive portfolio of products that cater to both domestic and international markets.